| 1 |
30430199 | Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma. | 2019 Feb |
1 |
| 2 |
27725879 | Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing. | 2016 |
1 |
| 3 |
21029698 | [Relationship between P-glycoprotein function in peripheral blood cells and multidrug resistance in breast carcinoma]. | 2010 Jul |
1 |
| 4 |
21133625 | Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India. | 2010 |
1 |
| 5 |
17268526 | The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines. | 2007 Apr |
1 |
| 6 |
17274671 | Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance. | 2007 Jan-Feb |
2 |
| 7 |
16159384 | Anthracyclines, proteasome activity and multi-drug-resistance. | 2005 Sep 13 |
1 |
| 8 |
15294454 | Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06. | 2004 Sep 1 |
1 |
| 9 |
11391630 | Determining MDR1/P-glycoprotein expression in breast cancer. | 2001 Jul 1 |
2 |
| 10 |
11426555 | Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia. | 2001 Jan |
1 |
| 11 |
11518560 | Fluorescent verapamil analogue for monitoring acidic intracellular organelles in multidrug resistant and sensitive cells. | 2001 Jul 31 |
1 |
| 12 |
10500834 | New developments in the treatment of acute myeloid leukemia. | 1999 |
1 |
| 13 |
9029024 | A low but functionally significant MDR1 expression protects primitive haemopoietic progenitor cells from anthracycline toxicity. | 1997 Feb |
1 |
| 14 |
9054575 | Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge. | 1997 Mar 4 |
2 |
| 15 |
9175315 | Effect of fludarabine and arabinosylcytosine on multidrug resistant cells. | 1997 Mar-Apr |
2 |
| 16 |
9021691 | Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells. | 1996 Sep |
1 |
| 17 |
7737146 | Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. | 1995 Mar 15 |
1 |